Equity Overview
Price & Market Data
Price: $1.90
Daily Change: -$0.0711 / 3.74%
Range: $1.83 - $1.95
Market Cap: $3,744,440
Volume: 41,231
Performance Metrics
1 Week: -9.71%
1 Month: -5.10%
3 Months: -33.33%
6 Months: -38.00%
1 Year: -87.15%
YTD: -44.56%
Company Details
Employees: 6
Sector: Health technology
Industry: Pharmaceuticals: major
Country: Israel
Details
PainReform Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel. It develops PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia, as well as in Phase 3 clinical trial for pain treatment of patients undergoing bunionectomy and pain treatment of hernia repair operations. The company was incorporated in 2007 and is based in Tel Aviv, Israel.